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Ephrin-A5/EphA4 signalling controls specific
afferent targeting to cochlear hair cells
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Hearing requires an optimal afferent innervation of sensory hair cells by spiral ganglion
neurons in the cochlea. Here we report that complementary expression of ephrin-A5 in hair
cells and EphA4 receptor among spiral ganglion neuron populations controls the targeting of
type I and type II afferent fibres to inner and outer hair cells, respectively. In the absence of
ephrin-A5 or EphA4 forward signalling, a subset of type I projections aberrantly overshoot the
inner hair cell layer and invade the outer hair cell area. Lack of type I afferent synapses
impairs neurotransmission from inner hair cells to the auditory nerve. By contrast, radial shift
of type I projections coincides with a gain of presynaptic ribbons that could enhance the
afferent signalling from outer hair cells. Ephexin-1, cofilin and myosin light chain kinase act
downstream of EphA4 to induce type I spiral ganglion neuron growth cone collapse. Our
findings constitute the first identification of an Eph/ephrin-mediated mutual repulsion
mechanism responsible for specific sorting of auditory projections in the cochlea.
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H
earing requires an optimal innervation of sensory hair
cells (HCs), which transduce the acoustic signal. HCs
receive two different types of innervation: afferent
innervation from spiral ganglion (SG) neurons (SGNs)1,2 and
efferent innervation from the superior olivary complex2–4. The
primary afferent innervation includes two functionally distinct
neuronal populations conveying sound information from the
cochlea to the central nervous system. In the adult sensory
epithelium, the organ of Corti (OC), each inner HC (IHC)
connects over 10 type I SGNs (about 90–95% of the neuronal
population) and represents the principal encoder of the auditory
signal. By contrast, outer HCs (OHCs) display an ‘en passant’
innervation by type II SGNs (approximately 5–10% of the total
neuronal population) (Fig. 7a). The function of these type II
connections is still unclear, but they may monitor and regulate
OHC gain.
In rodents, the development of cochlear innervation starts at
early embryonic stages and is completed by the end of the first
postnatal week. This process is divided into three main phases: (a)
neurite growth and extension of type I and type II afferents to
HCs (before birth), (b) axon refinement and HC innervation
(postnatal day 0; P0–P3) and (c) neurite retraction and synaptic
pruning (P3–P6)5. Axon guidance depends on the motility of
navigating growth cones that respond to nondiffusible
extracellular matrix molecules, transmembrane proteins
expressed in neighbouring cells and diffusible chemotropic
agents released by the target epithelium. These cues successively
exert either repulsive or attractive influences on outgrowing axons
and finally give rise to accurate targeting of auditory projections6.
Importantly, although the mechanisms required for axon
guidance to the OC become better characterized, the molecules
underlying the specific refinement of type I and type II afferents
to respective HCs remain elusive.
Among gene families that have been shown to regulate neurite
guidance, ephrins and their Eph receptors are good candidates for
patterning auditory neural connectivity. Ephrin-As and EphA
receptors are often expressed in complementary gradients in
target cells and projecting neurons, respectively7,8. Particularly,
both in vitro and in vivo findings have shown that ephrin-A5
induces growth cone collapse and axon repulsion upon binding to
EphA receptors, avoiding formation and stabilization of axon
branching and arborization at inaccurate locations9.
This large Eph family has been classified into two subclasses,
EphA and EphB, according to their affinity for either glycosyl-
phosphatidylinositol-anchored ephrin-A or transmembrane
ephrin-B ligands10. Immunohistochemical studies previously
suggested alternating expression patterns of ephrins and Eph
receptors in the developing inner ear11,12.
On the basis of their well-described role in topographic
mapping in several parts of central and peripheral nervous
systems, we suggested that ephrin/Eph genes control the proper
patterning of radial SGN projections in the cochlea. Here we
found that ephrin-A5 and EphA4, expressed, respectively, in
OHCs and type I SGNs, display complementary expression
profiles at perinatal stages. In the absence of ephrin-A5 or EphA4
forward signalling, a subset of type I projections aberrantly
overshoot the IHC layer and invade the OHC area, thereby
suggesting an Eph/ephrin-mediated mutual repulsion mechanism
responsible for specific afferent targeting to cochlear HCs.
Results
Differential expressions of ephrin-A5 and EphA4. Among the
ephrin ligand family, ephrin-A5 is most commonly involved in
topographic map specification through graded expression in the
target region9,13,14. We therefore examined the ephrin-A5
expression in HCs during the formation of radial afferent
projections in the cochlea. Ephrin-A5 mRNA and protein are
specifically detected in OHCs between E18 and P4 (Fig. 1j–n and
Supplementary Fig. S1a–c), a period characterized by neurite
refinement and HC innervation7. Surprisingly, ephrin-A5 is also
expressed in a subset of type I SGNs (Fig. 1j,o–t and
Supplementary Fig. 1d–f). This ephrin-A5þ SGN subpopulation
reaches a peak at P0 (Fig. 1u and Supplementary Fig. 1d,e).
During the same time window, EphA4 is widely expressed in SG
cells, especially in bIII-tubulinþ SGNs (Fig. 1a,c,d,i and
Supplementary Fig. S1g–l). However, both transcript and
EphA4EGFP remain preferentially confined to type I SGNs.
Indeed, peripherinþ type II SGNs15 are negative for EphA4
expression (Fig. 1a,b,d–f). Among Eph receptors (that is, EphAs
and EphB2 (ref. 16)) that interact with ephrin-A5, EphA4 is the
only one exhibiting such striking expression pattern in the SG,
distinguishing type I from type II SGNs. EphA4EGFP is also
detectable in fibres that are specifically retained to IHCs at P2
(Fig. 1g,h). Taken together, these results suggest that ephrin-A5
and EphA4 display matching complementary expression profiles
at perinatal stages (Fig. 1v), consistent with a role in specific
afferent targeting to HCs in the cochlea.
Mistargeting of afferent fibres to HCs in ephrin-A5 /
cochlea. To assess the role of ephrin-A5 in contributing to proper
cochlear innervation, we performed neurofilament H (NF-H) and
peripherin co-immunostaining on whole-mount post-hearing-
onset (P14) cochleae17 from wild type (WT) and ephrin-A5 /
littermates9. Compared with the WT phenotype, a radial shift in
innervation pattern from IHCs to OHCs is observed in ephrin-
A5 / mice (Fig. 2a–f). In WT mice, most axons contacting
OHCs belong to type II SGNs (NF-Hþ /peripherinþ ) (Fig. 2g,h),
as previously described15. By contrast, a large majority of fibres
targeting the OHCs in ephrin-A5 / animals correspond to
peripherin ectopic innervation (Fig. 2i,j). Quantitative analysis
revealed that the number of NF-Hþ /peripherin projections to
the OHC region is significantly increased in ephrin-A5 / P14
littermates (Fig. 2u). This suggests that loss of ephrin-A5
expression allowed a subset of type I SGNs to target the OHC
layer instead of wiring with IHCs. In addition, although type II
SGNs classically exhibit extensive arborization and innervate
several OHCs in WT (Fig. 2h), they send shortened projections in
ephrin-A5 / mice (Fig. 2j). The percentage of type II fibres
whose length is o or 4 to 200 mm after entering the OC is,
respectively, increased and decreased in ephrin-A5 / cochleae
as compared with WT (Fig. 2v). This defect probably arises from
axon competition induced by massive ectopic projections
randomly invading the OHC area. Importantly, the number of
IHC and OHC rows (1 and 3, respectively) and the number of
total SGNs and peripherinþ type II SGNs remain unchanged in
the absence of ephrin-A5 (Supplementary Figs S2 and S3a–f).
Sensory synapses of the auditory system must faithfully encode
a wide dynamic range of graded signals, and must be capable of
sustained transmitter release over long periods of time. These
properties require specialized structures called synaptic ribbons.
These ribbons are electron-dense presynaptic specializations that
tether synaptic vesicles, allowing rapid exocytosis and fast
synaptic transmission18,19. The major structural component of
synaptic ribbons identified so far is RIBEYE, a protein aggregate
formed by a unique and ribbon-specific A domain, and a dimeric
B domain identical to CtBP2, a transcriptional repressor
protein20. In the mammalian cochlea, outside of the extreme
apex, 495% of cochlear nerve fibres are unbranched, contacting a
single IHC via a single terminal swelling, with a single active zone
at which a single presynaptic ribbon is tethered to the IHC
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membrane21. Thus, ribbon quantifications provide an accurate
metric of the IHC afferent innervation22. It has to be pointed out
that CtBP2þ ribbons are not systematically coupled to NF-Hþ
staining, because neurofilaments do not fill terminal axon
swellings22. Consistent with the finding that some type I SGNs
aberrantly project to the OHC region in ephrin-A5 / mice,
mean counts revealed a significant decrease of presynaptic active
zones per IHC in ephrin-A5 / compared with WT mice
(Fig. 2k–n,s). We then wondered whether the lack of IHC afferent
synapses in ephrin-A5 / cochlea coincides with a gain of OHC
synaptic ribbons. Ribbon counts revealed a significant increase of
presynaptic active zones per row of OHCs in ephrin-A5 /
compared with WT mice (Fig. 2o–r,t). Combination of both
results suggests that, in ephrin-A5 / mice, the radial shift of
type I projections from IHC to OHC layers is accompanied by a
similar radial displacement of presynaptic active zones.
Ephrin-A5/EphA4 is required for SGN projection sorting.
When present in target cells, ephrin-A5 induces axon growth
cone repulsion through activation of EphA receptors, avoiding
propagation of ectopic projections in the region of expression9,23.
To further understand the mechanism of axonal refinement in the
OC occurring between P0 and P3, we considered using whole-
mount cochleae from 2-day-old WT and ephrin-A5 / mice
(Fig. 3a). At this stage, growing type I projections that have
reached the first row of OHCs are progressively redirected to the
basolateral region of IHCs5. In that respect, we observed that, in
WT animals, most of the growing axons are stopped just beneath
the first row of OHCs (Fig. 3b,d). By contrast, almost no refining
fibres are distinguishable in the absence of ephrin-A5. A huge
amount of neurites, instead of being repulsed by ephrin-A5þ
OHCs, abnormally overshoot the IHC layer and give rise to an
aberrant OHC projection pattern (Fig. 3c,e). The proportion of
fibres targeting the OHC layer is significantly higher in ephrin-
A5 / compared with WT animals (Fig. 3l).
To ascertain the requirement of ephrin-A5 in specific SGN
afferent targeting to HCs, we used an organotypic assay, in which
explants of OC and SG (devoid of efferent fibres from the
brainstem) were isolated from E18 cochleae and cultured in order
to examine the effect of acute ephrin-A5 signalling inhibition
in vitro. To avoid any disruption with findings suggesting an
EphA4-mediated axon guidance to the OC through binding to
ephrin-B2 and -B3 (refs 24,25), we preferred to treat with soluble
EphA7-Fc known to have a high affinity for ephrin-A510 rather
than with EphA4-Fc. Tissues were maintained for 4 days in
culture to analyse the processes of selective neurite refinement
and HC innervation (Fig. 3a). In the control condition (IgG-Fc),
the majority of growing axons are ending at the IHC level
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Figure 1 | Complementary expression patterns of ephrin-A5 and EphA4 in HCs and SGNs. (a,b) Confocal images of SG cells on transversal section of P0
cochlea processed for ISH with EphA4 probe (a) and for peripherin immunostaining (b). Note that peripherinþ type II SGNs (arrowheads in b) expressed
lower levels of EphA4 as compared with peripherin cells. (c–f) Triple immunolabeling on transversal section of SG from P0 EphA4þ /EGFP mouse
showing that EphA4EGFP is expressed in SGNs (yellow arrowheads in c,d,f) but absent from peripherinþ type II SGNs (white arrowhead in d–f).
(g,h) Immunolabeling of whole-mount P2 EphA4þ /EGFP cochlea showing the presence of EGFP (arrowheads in g) in NF-Hþ fibres (arrowheads in h)
retained at IHCs. ISH on transversal sections of P2 (i) and P0 (j) cochleae showing the expression of EphA4 (i) and ephrin-A5 (j) along the basal-to-apical
axis of the cochlea. (k–n) ISH (k) and immunolabeling (l–n) on transversal section of a newborn mouse OC showing a prominent expression of ephrin-A5
mRNA and protein in OHCs compared with IHC. (o–t) Confocal images of SG on transversal section of P0 cochlea processed for ISH with ephrin-A5 probe
(o,q,s) and for bIII-tubulin (p,r) or peripherin immunostaining (t). Note that ephrin-A5 is expressed in a subset of SGNs (blue arrowhead in q, yellow
arrowhead in r) but is absent from peripherinþ type II SGNs (blue arrowheads in s, yellow arrowheads in t). (u) Quantification of ephrin-A5þ SGNs across
developmental stages. This ephrin-A5þ SGN subpopulation reaches a peak at P0. Data are presented as mean±s.e.m. (v) Schematic representation of
ephrin-A5 (blue)/EphA4 (green) complementary expressions in HCs and SGNs in the perinatal cochlea. Note that ephrin-A5 expression likely
overlaps EphA4 in a subset of type I SGNs. Scale bars in (a) represents 10mm in (a,b), in (c), (g) and (k) 5 mm in (c–f,q–t), (g,h) and (k–n) respectively, in
(i) and (o) 25mm in (i,j) and (o,p) respectively.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2445 ARTICLE
NATURE COMMUNICATIONS | 4:1438 | DOI: 10.1038/ncomms2445 | www.nature.com/naturecommunications 3
& 2013 Macmillan Publishers Limited. All rights reserved.
most fibres extend radially to the OHC area (Fig. 3i,k). The
proportion of afferent fibres targeting the OHC layer is
significantly higher in EphA7-Fc compared with the control
condition (Fig. 3n) without affecting neuron survival
(Supplementary Fig. S3m,n,r). Both control and EphA7-Fc
culture conditions seem to faithfully reproduce the stage of
neurite refinement to HCs observed at P2 in WT and ephrin-
A5 / mice, respectively. These results confirm the involvement
of ephrin-A5 in specific afferent targeting to HCs in the cochlea.
In support of this finding, a neuronal tracing experiment revealed
that ephrin-A5 / mice do not display any radial shift in
efferent innervation pattern from IHCs to OHCs compared with
WT animals (Supplementary Fig. S4). Altogether, these results
indicate that mistargeting of afferent fibres is the single cause of
the radial shift in HC innervation pattern observed in ephrin-
A5 / cochleae.
To test whether EphA4 is the receptor through which ephrin-
A5 induces sorting of SGN projections, we used a mouse
line encoding an EphA4 forward signalling-deficient isoform26.
The proportion of fibres targeting the OHC layer was found to be
significantly higher in EphA4EGFP/EGFP compared with WT
animals both at P2 (Fig. 3f,g,m) and after hearing onset
(Fig. 4a–j,q). Ribbon counts confirmed this radial shift from the
IHC layer to the OHC layer in EphA4EGFP/EGFP mice (Fig. 4k–p),
whereas both bIII-tubulinþ (type I and II) and peripherinþ
(type II) SGN survival remain unchanged (Supplementary Fig.
S3g-l). In contrast, the percentage of type II fibres whose length is
o or 4 to 200mm after entering the OC is, respectively,
increased and decreased in EphA4EGFP/EGFP mice as compared
with WT (Fig. 4g–j,r), suggesting a mechanism of axon
competition. Mimicking the ephrin-A5 / phenotype, these
results therefore suggest that EphA4 forward signalling is
required for sorting of radial SGN projections.
Ephrin-A5/EphA4 induces type I SGN growth cone collapse.
To confirm the hypothesis that EphA4 is required for type I
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Figure 2 | Radial shift in afferent HC innervation pattern in ephrin-A5 / cochlea. (a–f) NF-H immunolabeling alone (a,b) or in combination with
myosin-VII (c–f) of whole-mount cochleae from post-hearing-onset WT (a,c,d) and ephrin-A5 / (b,e,f) mice. Loss of ephrin-A5 induces a radial shift in
innervation pattern from the IHC to the OHC layers. The yellow dotted curve delimits the area of projections to OHCs. (g–j) Double immunolabeling for NF-
H (g,i) and peripherin (h,j) on whole-mount cochleae from WT and ephrin-A5 / mice. (g,h) In WT mice, almost all projections to OHCs are identified as
type II fibres (NF-Hþ/peripherinþ ) and exhibit extensive arborization (yellow arrowheads). (i,j) In ephrin-A5 / mice, the OHC innervation is more
abundant and largely attributable to ectopic NF-Hþ/peripherin projections. In addition, type II afferents (peripherinþ ) show incomplete innervation
(yellow arrowheads) compared with WT. Yellow brackets indicate the OHC area. (k–n) Double NF-H—CtBP2/RIBEYE immunolabeling focused on IHCs
from WT (k,l) and ephrin-A5 / (m,n) mice. (o–r) Triple NF-H—parvalbumin—CtBP2/RIBEYE immunolabeling focused on OHCs from WT (o,p) and
ephrin-A5 / (q,r) mice. (s) The number of synaptic ribbons per IHC is significantly reduced in ephrin-A5 / compared with WT mice (n¼ 3 animals for
both genotypes; **Po0.01). (t) The number of synaptic ribbons per row of OHCs is significantly increased in ephrin-A5 / compared with WT mice
(n¼ 3 animals for both genotypes; **Po0.01). (u) The number of NF-Hþ/peripherin fibres targeting the OHC layer is significantly increased in ephrin-
A5 / compared with WT mice (n¼ 3 animals for both genotypes; ***Po0.001). (v) The percentage of type II fibres of which length isoor4to 200mm
after entering the OC is, respectively, significantly increased and decreased compared with WT (n¼ 3 animals for both genotypes; **Po0.01). Statistical
significance was determined using Student’s t-test. Data are presented as mean±s.e.m. Scale bars in (a) represent 50mm in (a,b) and 10 mm in (c–f), in (g)
10mm in (g–j), in (l) 5 mm in (k–r), respectively.
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Figure 3 | Ephrin-A5/EphA4 forward signalling is required for the sorting of radial SGN projections. (a) Schematic representation of in vivo and
in vitro protocols used to analyse cochlear innervation. (a) Type I and type II neurite extension to HCs (before birth), (b) neurite refinement and HC
innervation (P0–P3) and (c) neurite retraction and synaptic pruning (P3–P6). WT and ephrin-A5 / mice were killed at P2 (red cross). Explants of OC and
SG from E18 embryos were treated in vitro with EphA7-Fc during 4 days (red bar). (b–g) Immunolabeling for NF-H alone or in combination with
parvalbumin of whole-mount cochlea from P2 WT, ephrin-A5 / and EphA4EGFP/EGFP mice. (b,d,f) In WT condition, most growth cones (arrowheads) stop
beneath the first row of OHCs (dotted line). In ephrin-A5 / (c,e) or EphA4EGFP/EGFP (g) mice, almost no collapsed growth cones can be observed,
whereas many fibres aberrantly invade the OHC layer. (h–k) In vitro organotypic model using SG and OC cultured in the presence of control (IgG-Fc; h,j) or
the soluble inhibitor EphA7-Fc (i,k) reagents. Double immunolabeling for bIII-tubulin and parvalbumin. (h,j) In the control condition, almost all afferent
projections are retained to IHCs, and some stopping growth cones (arrowheads) can be observed at the limit between IHC and OHC layers (yellow dotted
line). (i,k) When blocking endogenous ephrin-A5 signalling, a majority of fibres project to the OHC layer. (l,m) The proportion of fibres targeting the OHC
region is significantly increased in ephrin-A5 / (l) and EphA4EGFP/EGFP (m) versus WT mice (n¼ 3 animals for each genotype, **Po0.01, ***Po0.001).
(n) The proportion of afferent fibres targeting the OHC region is significantly increased in EphA7-Fc versus IgG-Fc condition (n¼ 3 independent
experiments for both conditions; **Po0.01). Statistical significance was determined using Student’s t-test. Data are presented as mean±s.e.m. Scale bars
in (b) and (h) represent 5 mm in (b–g) and (h–k), respectively.
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growth cone collapse assays, in which dissociated SGNs from
newborn mouse cochleae are exposed to pre-clustered ephrin-A5.
After treatment, the majority of SGN neurites undergo growth
cone collapse, as revealed by the F-actin marker phalloidin
(Fig. 5b). The size reduction of growth cones (compare Fig. 5a,b)
is correlated with phosphorylation of EphA4 on tyr-602
residue (Fig. 5b)27. By contrast, SGNs preferentially show
large growth cones in the control condition, with no detectable
EphA4 phopho-specific immunolabeling (Fig. 5a). Importantly,
growth cones of peripherinþ type II SGNs appear not sensitive to
pre-clustered ephrin-A5, and remain similar to those found in
the control condition (Fig. 5f). Quantitative analysis revealed
that the proportion of type I growth cone collapse is significantly
increased upon stimulation with ephrin-A5-Fc compared with
the control condition (Fig. 5q). Such a result was confirmed
using an in vitro stripe assay, in which a majority of SG
growth cones avoid the ephrin-A5-Fc-containing stripes
(Supplementary Fig. 5). On the contrary, type I SGN growth
cones from EphA4EGFP/EGFP mice, in which EGFP is expressed,
do not collapse in the presence of ephrin-A5-Fc (Fig. 5g,q).
These results therefore suggest that ephrin-A5 selectively induces
growth cone collapse on type I SGNs through specific activation
of EphA4.
We then tested whether the RhoA-associated kinase (ROCK)/
myosin light chain kinase (MLCK) signalling pathway is involved
in ephrin-A5-induced growth cone collapse, as previously shown
in retinal ganglion cell28 and hippocampal explant cultures29,
respectively. Incubation of either p160 ROCK-specific inhibitor
Y-27632 or MLCK inhibitor ML-7 in primary culture of SGNs
result in a significant rescue of ephrin-A5-induced growth cone
collapse (Fig. 5q). These results were confirmed in organotypic
culture assay. Blocking either ROCK or MLCK results in a
WT EphA4EGFP/EGFP EphA4EGFP/EGFP







































































































































Figure 4 | Radial shift in HC afferent innervation pattern in post-hearing-onset EphA4 forward-signalling-deficient mice. (a–f) NF-H immunolabeling
alone (a,b) or in combination with myosin-VII (c–f) of whole-mount cochleae from post-hearing-onset WT (a,c,d) and EphA4EGFP/EGFP (b,e,f) animals.
Loss of EphA4 forward signalling induces a radial shift in innervation pattern from IHC to OHC layers. The yellow dotted curve delimits the area of
projections to OHCs. (g–j) Double immunolabeling for NF-H (g,i) and peripherin (h,j) on whole-mount cochleae from WT and EphA4EGFP/EGFP mice.
(g,h) In WT mice, almost all projections to OHCs are identified as type II fibres (NF-Hþ/peripherinþ ) and exhibit extensive arborization (yellow
arrowheads). (i,j) In EphA4-knocking mice, the OHC innervation is more abundant and largely attributable to ectopic NF-Hþ/peripherin projections.
In addition, type II afferents (peripherinþ ) show incomplete innervation (yellow arrowheads) compared with WT. Yellow brackets indicate the OHC area.
(k,l) Double parvalbumin—CtBP2/RIBEYE immunolabeling focused on OHCs from WT (k) and EphA4EGFP/EGFP (l) mice. (m,n) CtBP2/RIBEYE
immunolabeling focused on IHCs from WT (m) and EphA4EGFP/EGFP (n) mice. (o) The number of synaptic ribbons per IHC is significantly reduced in ephrin-
A5 / compared with WT mice (n¼ 3 animals for both genotypes; ***Po0.001). (p) The number of synaptic ribbons per row of OHCs is significantly
increased in EphA4EGFP/EGFP compared with WT mice (n¼ 3 animals for both genotypes; *Po0.05). (q) The number of NF-Hþ/peripherin fibres
targeting the OHC layer is significantly increased in EphA4EGFP/EGFP compared with WT mice (n¼ 3 animals for both genotypes; **Po0.01).
(r) The percentage of type II fibres whose length isoor4to 200mm after entering the OC is, respectively, significantly increased and decreased compared
with WT (n¼4 animals for both genotypes; *Po0.05). Statistical significance was determined using Student’s t-test. Data are presented as mean±s.e.m.
Scale bar in (a) represents 50mm in (a,b), in (c) and (g) 10mm in (c–f) and (g–j), respectively, in (k) 5 mm in (k–n).
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radial shift of afferent innervation pattern from IHC to OHC
layers as compared with control (dimethylsulphoxide) condition
(Fig. 5k–p,r), without affecting neuron survival (Supplementary
Fig. S3o–r). In addition, we found that growth cone collapse
coincides with phosphorylation of three potential downstream
signalling proteins of EphA4: the guanine nucleotide exchange
factor ephexin-130, the actin-depolymerizing and -severing factor
cofilin-131 and the ATP-dependent motor protein myosin-2
(responsible for actin-based motility)32 (Fig. 5h,i,j, respectively).
These findings support a requirement of the RhoA-ROCK/cofilin/
MLCK signalling pathway downstream of EphA4 receptor
activation by ephrin-A5 (Fig. 7d).
Ephrin-A5 is required for optimal IHC neurotransmission. To
assess the hearing function when ephrin-A5 is missing, we
performed auditory brainstem response (ABR) recordings on 3-
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Figure 5 | Ephrin-A5 induces growth cone collapse on type I SGNs through activation of EphA4. (a,b,f,g) Representative examples of in vitro growth
cone collapse assay on dissociated SGNs from newborn mice using control IgG-Fc or pre-clustered ephrin-A5-Fc. (a) In the control condition, SGNs show a
large growth cone with no sign of EphA4 phosphorylation. (b) Upon incubation with pre-clustered ephrin-A5-Fc, F-actin marker tetramethyl rhodamine
isothiocyanate-phalloidin (red) reveals severe growth cone collapse simultaneously co-localized with EphA4 phospho-specific (tyr-602) immunolabeling.
(f) Growth cones of type II SGNs (peripherinþ , green) are not sensitive to clustered ephrin-A5, and their structure remains similar to those observed in the
control condition. (g) Type I SGN growth cones from EphA4EGFP/EGFP mice, in which EGFP is expressed, do not collapse in the presence of ephrin-A5-Fc.
(c–e,h–j) Signalling proteins downstream of EphA4 activation. Ephrin-A5-induced growth cone collapse coincides with phosphorylation of ephexin-1 (h),
cofilin (i) and myosin light chain-2 (MLC-2) (j) compared with control condition (c,d,e). (k–p) In vitro organotypic model using SG and OC cultured in the
presence of dimethylsulphoxide (k,n), Y-27632 (l,o) or ML-7 (m,p). (k,n) Under control conditions, almost all afferent fibres are retained to IHCs and some
stopping fibres (arrowheads) can be observed at the limit between IHC and OHC layers (yellow dotted line). When blocking endogenous ROCK (l,o) or
MLCK (m,p) signalling pathways, a majority of fibres project to the OHC layer. (q) The proportion of type I growth cone collapse is significantly increased
upon stimulation with ephrin-A5-Fc compared with the control condition, but not when type I SGNs lack EphA4 forward signalling. This effect is
significantly rescued by pre-treatment with either Y-27632 or ML-7. By contrast, the proportion of type II growth cone collapse is not increased upon
stimulation with ephrin-A5-Fc compared with the control condition. n¼ 3 independent experiments for each condition. **Po0.01, ***Po0.001. (r) The
percentage of afferent fibres targeting the OHC layer is significantly increased in the presence of either Y-27632 or ML-7 inhibitors. n¼ 3 independent
experiments for each condition. **Po0.01 Statistical significance was determined using one-way ANOVA test followed by a Dunnett’s post-test. Data are
presented as mean±s.e.m. Scale bars in (a) and (k) represent 5 mm in (a-j) and (k–p), respectively.
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shift in HC innervation pattern is conserved until adulthood
(as shown in the apical turn, Supplementary Fig. S6). ABR
measurements were obtained using click stimuli. Hearing
thresholds remained similar for both genotypes (Fig. 6a). How-
ever, ABR amplitudes to suprathreshold click stimuli were altered
in ephrin-A5 / animals. In particular, ABR peak 1 amplitude
reflecting the summed activity of cochlear afferents33,34 is
significantly decreased at several intensity levels and, on
average, is 40% smaller in mice lacking ephrin-A5 (Fig. 6b,c).
This deficient neurotransmission probably arises from reduced
number of IHC afferent connections by type I SGNs caused by
partial mistargeting of type I projections to OHCs (Fig. 2 and
Supplementary Fig. S6).
Discussion
In the mid 1990s, it was suggested that brain-derived neuro-
trophic factor and neurotrophin-3 specifically support the
innervation of OHCs and IHCs through activation of trkB or
trkC receptors on type II and type I SGNs, respectively35.
However, further studies revealed that, even if neurotrophins via
trk receptors clearly promote SGN survival and fibre outgrowth
during development, these molecules fail to explain by themselves
the formation of proper afferent connections between HCs and
SGNs36.
In this study, we provide a model describing how type I and
type II SGNs specifically innervate IHCs and OHCs, respectively.
This mechanism involves complementary and specific spatio-
temporal expressions of ephrin-A5 in OHCs and EphA4 in type I
SGNs throughout the perinatal period of axonal refinement
leading to HC innervation (Fig. 1)5. Analysis of ephrin-A5 /
mice suggests that a subset of type I SGNs overshoot the IHCs
and abnormally project into the OHC region, adopting
consequently the behaviour of type II innervation (Fig. 7b).
This phenotype was reproduced by in vitro organotypic assay
when blocking ephrin-A5-binding ability with a soluble inhibitor
(EphA7-Fc), arguing that type I SGNs express an appropriate
EphA/EphB2 receptor needed to specifically interact with ephrin-
A5. Differentially expressed among SGN populations, EphA4
was also found to be specifically activated through selective
ephrin-A5-mediated type I growth cone collapse (Fig. 5). In
addition, forward signalling-deficient EphA4EGFP/EGFP mice
provide a radial shift in HC afferent innervation pattern
comparable to the one observed in ephrin-A5 / animals.
Given the crucial involvement of ephrin-A5/EphA4 interactions
in establishing thalamocortical mapping13, we believe that, in the
cochlea, the auditory innervation pattern is achieved on a similar
model. Indeed, we show that EphA4þ type I SGNs connect
ephrin-A5 IHCs, whereas despite the presence of repulsive cues
in target cells EphA4 type II SGNs manage to project to ephrin-
A5þ OHCs (Fig. 7a and c). Thus, it is tempting to speculate that
EphA4 is the partner of ephrin-A5 in this repulsive/permissive
system. In contrast, EphB2, although known to interact with
ephrin-A516, does not seem to be a good candidate, as it is equally
expressed in both type I and type II SGNs.
This model is compatible with recent data showing that, during
the anterior stage of fibre outgrowth and extension to the OC,
EphA4 is expressed in the otic mesenchyme and interacts with
ephrin-B2 on developing SGN axons25. Indeed, it can be
suggested that, at late embryonic stages, EphA4 promotes SGN
fasciculation through ephrin-B2 reverse signalling; once afferents
have reached the OC, EphA4 (expressed in type I SGNs) forward
signalling controls target specification through interaction with
ephrin-A5 (expressed by OHCs) at early postnatal stages.
Importantly, this hypothesis of a double role for EphA4 is
supported by the fact that, in addition to be expressed in the otic
mesenchyme, EphA4 mRNA was also found in the SG25.
Perinatally, during HC innervation process, although type I
fibres are specifically refined to basolateral regions of IHCs, some
collateral branches (CBs) establish temporary synaptic contacts
with OHCs that are pruned at later stages5,37,38. Importantly,
numerous type I SGNs have both a main fibre refining to IHC
and a CB forming a transient synapse with OHCs. How do these
transient projections manage to reach ephrin-A5þ target cells?
We observed that, in addition to be expressed in OHCs, ephrin-
A5 seems to be dynamically expressed at perinatal stages in a
subset of SGNs that do not belong to type II SGNs, therefore
partially overlapping the expression of EphA4 (Fig. 1o–u).
Although we found that this ephrin-A5þ SGN subpopulation
reaches a peak at P0, knowing exactly whether this is a consistent
subpopulation or whether type I SGNs are all expressing ephrin-
A5 but at different times remains to be determined. Depending
on the local neural network to be formed, recent work has shown
that coexpressed Eph and ephrins cis-interact and mutually
inactivate each other in the same cell, thereby fine-tuning the
sensitivity of navigating axons to ephrins from the target tissue
presented in trans39–41. Furthermore, the relative contribution of
trans signalling and cis attenuation is influenced by the
subcellular distribution of both ephrins and Ephs39,42.
Therefore, it can be hypothesized that, within a given type I
SGN in which EphA4 and ephrin-A5 are coexpressed, the
presence of ephrin-A5 protein is exclusively confined to the CB,
where it could mediate cis silencing of EphA4 forward signalling,










































































Figure 6 | Ephrin-A5 is required for optimal neurotransmission from IHCs to the auditory nerve. (a) Hearing thresholds are similar in both WT and
ephrin-A5 / mice. ABR measurements were established using click stimuli. (b) ABR waveforms from ephrin-A5 / (grey) exhibit decreased
peak I amplitude compared with WT (black) mice. Peak II is generated by the central portion of VIIIth cranial nerve; Peak III by the cochlear nucleus; Peak IV
by the superior olivary complex/lateral lemniscus; Peak V by the lateral lemniscus/inferior colliculus. (c) Peak I amplitude is significantly reduced
when using 30, 40, 50, 60 and 80 dB SPL stimulation and, on average, is 40% smaller in ephrin-A5 / mice. n¼ 12 animals for both genotypes. *Po0.05,
**Po0.01. Statistical significance was determined using Student’s t-test. Data are presented as mean±s.e.m.
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Figure 7 | Schematic model summarizing the contribution of ephrin-A5/EphA4 in afferent targeting to HCs in the OC. (a,b) Ephrin-A5 (blue) and
EphA4 (green) genes are expressed at perinatal stages in OHCs and type I SGNs, respectively. These complementary patterns match one another given the
known SG to HCs topography, with type I SGNs connecting IHCs and type II SGNs (purple) widely projecting to OHCs (purple arrowheads in A). (a) In the
WT condition, ephrin-A5 from OHCs provides a repulsive signal to EphA4þ type I axons (green). (b) In the absence of ephrin-A5, a subset of type I
SGNs send ectopic projections to the OHCs region, giving rise to incomplete type II innervation (purple arrowheads indicate the new early endpoints)
compared with WT (purple arrowheads in A). (c,d) A model for how ephrin-A5/EphA4 interactions control specific SGN afferent targeting to
corresponding HCs. (c) When EphA4þ type I SGNs reach ephrin-A5 IHCs, ephexin-1 is stably bound to EphA4 at the membrane, where it contributes to
activation of RhoA, among other GTPases. RhoA supports a basal level of actomyosin-based contractility resulting in a forward movement. (d) When
EphA4þ type I SGNs reach ephrin-A5þ OHCs, EphA4 activation enhances ephexin-1 activity toward RhoA. ROCK activation inhibits both cofilin-mediated
f-actin depolymerization and myosin light chain phosphatase activity, favouring the accumulation of f-actin stress fibres and phospho-myosin light
chain-2. Both components synergistically increase the actomyosin-based contraction, leading to growth cone collapse, therefore preventing type I SGN
from targeting the OHCs. In red, the elements that were experimentally tested. limK, lim kinase; mlc, myosin light chain; mlcp, mlc phosphatase; mlck,
mlc kinase.
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formation of transient type I—OHC synapses. By contrast, in the
meantime, the main type I fibre would remain EphA4þ /ephrin-
A5 , involving the repulsion of type I fibre upon binding to
ephrin-A5þ OHCs and the subsequent refinement to IHCs
(Supplementary Fig. 7).
In WT condition, type II afferents enter the OHC area
relatively apically, turn to the base, arborize extensively and
innervate tens of cells. Although previous work supports the fact
that neurite growth of type II SGNs is highly directed towards
OHCs43, the mechanisms (neurotrophic or intrinsic) that would
underlie this process remain largely unclear. Here we found that
the absence of either ephrin-A5 or EphA4 forward signalling
induces random invasion of the OHC layer by numerous ectopic
fibres. Consequently, type II SGNs probably undergo axon
competition and adapt by forming incomplete projections. This
observation is consistent with the fact that competition for target
territory refines the map by suppressing or eliminating
branches44. Neuronal immunolabelings therefore reveal
opposite shifts: a partial displacement of type I innervation
from IHCs to OHCs and a subsequent withdrawal of type II
projections from OHCs. This double defect is similar to what
happens during retinocollicular map formation. Indeed, in the
absence of ephrin-A5 anteroposterior gradient in the superior
colliculus (SC) or EphA naso-temporal gradient in the retina,
temporal axons (TAs) shift posteriorly. Nasal axons (NAs)
therefore face increased competition in posterior SC, lose their
affinity for this region and spread out anteriorly14,45. On the basis
of gain- and loss-of-function analysis, a repulsion/competition
model accounting for normal mapping has been proposed14,46.
EphAþ TAs are strongly repelled by posterior ephrins, and thus
they terminate in the anterior SC. To avoid competition with TA
in the anterior SC, EphA NAs prefer to project only to the
posterior SC. As similar defects were obtained in both situations
using either ephrin-A5 / mice or in vivo loss of EphA function,
such a model could be transposed from retinocollicular mapping
to auditory projections pattern in the cochlea. EphA4þ type I
fibres are repelled by ephrin-A5 from OHCs to IHCs. Founded on
the observation that type II afferents fail to face strong type I axon
competition in the OHC region, EphA4 type II afferents could
not compete against multiple and dense type I connections at
IHCs and prefer to project to OHCs. Such an explanation is not
far from the idea that type I afferents may reach the OC earlier
and occupy the available membrane surface on IHCs, thus leaving
free synaptic space only on OHCs for type II fibers37. To precisely
address this competition hypothesis, a mouse line devoid of type I
SGNs should be created in order to observe whether, in the
absence of competition, some type II SGNs connect the IHCs.
Electrophysiological measurements revealed that ephrin-A5 is
dispensable for a normal hearing threshold. Given that type I
afferents initially indifferently reach both types of HCs5, in the
absence of ephrin-A5, a subset of type I projections should
directly connect IHCs without interacting with OHCs. This
residual type I innervation persisting at IHCs (Fig. 2) would
therefore be sufficient to preserve a normal hearing threshold.
However, an impaired neurotransmission from IHCs to the
auditory nerve was recorded in ephrin-A5 / animals and
should result from the partial type I SGN mistargeting to OHCs,
leading to the lack of IHC—type I afferent synapses. Interestingly,
EphA4 / mice show a similar decrease of ABR peak 1
amplitude47, reinforcing the hypothesis of a complementary
contribution to ephrin-A5 in specific afferent targeting to HCs.
Ribbon quantification revealed that radial shift of type I
projections from IHCs to OHCs in both ephrin-A5 / and
EphA4EGFP/EGFP mice is accompanied by an increased number of
presynaptic active zones in the OHC area (Figs 2and 4). During
the first postnatal week, type I SGNs extend transient collateral
projections to OHCs5 and form synapses that express glutamate
receptor subtypes48 and trigger Ca2þ - and otoferlin-dependent
glutamate release, similar to what occurs in mature IHCs49. In
adult cochlea, ribbons are believed to support afferent signalling
from OHCs50. Concurrently, these findings suggest the idea that,
in either ephrin-A5 / or EphA4 forward signalling-deficient
mice, some definitive type I—OHC ribbon-containing synapses
could enhance the afferent neurotransmission from this region.
Altogether, our results indicate that, rather than occurring by
any mechanisms of specific attraction as initially suggested35, the
precise targeting of type I SGNs—IHCs versus type II SGNs—
OHCs is dependent on ephrin-mediated mutual repulsion
through matching complementary expression patterns of ephrin
and Eph genes. This crucial finding could be usefully exploited in
therapeutic strategies aimed at improving the neurotransmission
from HCs to the cochlear nerve by selectively optimizing the
afferent innervation of either IHCs or OHCs.
Methods
Animals. WT and ephrin-A5 / , EphA4þ /EGFP and EphA4EGFP/EGFP littermates
were obtained from heterozygous crosses, and the genotype was determined by
PCR as previously described9,26. Mice were group-housed in the animal facility of
the University of Liège under standard conditions with food and water ad libitum
and were maintained on a 12-h light/dark cycle. All animals were taken care of in
accordance with the declaration of Helsinki and following the guidelines of the
Belgian ministry of agriculture in agreement with EC laboratory animal care and
use regulation (86/609/CEE, CE of J nL358, 18 December 1986).
In vitro organotypic assay. SG and OC were isolated together from E18 mouse
cochleae and cultured in DMEM (Gibco) supplemented with glucose (final con-
centration 6 g l 1) and N1 additives (insulin (5 mg ml 1), transferrin (5 mg ml 1),
putrescin (10 4 M), progesterone (2 10 8 M) and selenium ([Na2SeO3]
3 10 8 M)). Explants were treated with either IgG-Fc fragment as control or
recombinant mouse EphA7-Fc chimera (5mg ml 1; R&D Systems, Minneapolis,
MN, USA), an ephrin-A5 inhibitor, during 4 days. Explants were also treated
during the same time window with dimethylsulphoxide as control or Y-27632
dihydrochloride (10 mM; Tocris, Bristol, UK), a selective inhibitor of the RhoA-
associated protein kinase p160ROCK and ML-7 (10 mM; Sigma-Aldrich, St Louis,
MO, USA), a selective MLCK inhibitor.
Primary culture of SGNs and growth cone collapse assay. SGNs from newborn
mice were isolated, cultured as previously described51 and incubated with a
5 mg ml 1 human ephrin-A5-Fc (R&D systems, Minneapolis, MN, USA) solution
pre-clustered for 1 h at 37 C with 50mg ml 1 anti-human IgG-Fc (R&D systems,
Minneapolis, MN, USA). Before beginning growth cone collapse assay, cells were
pre-treated with either Y-27632 dihydrochloride (7 h, 10 mM; Tocris, Bristol, UK)
or ML-7 (5 h, 10mM; Sigma-Aldrich, St Louis, MO, USA). After incubation with
pre-clustered ephrin-A5 for 15 min in a humidified atmosphere of 5% CO2/95%
air, SGNs were then fixed in 4% paraformaldehyde and immunolabeled using
peripherin (rabbit polyclonal antibody, 1:100; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), EphA4 (tyr-602) phospho-specific (rabbit polyclonal antibody,
1:100; ECM Biosciences, Versailles, KY, USA), green fluorescent protein (rat
monoclonal IgG2a, 1:100; Gentaur, London, UK), ephexin-1 (tyr-87) phospho-
specific (rabbit polyclonal antibody, 1:100; ECM Biosciences, Versailles, KY, USA),
phospho-myosin light chain 2 (ser-19) (rabbit polyclonal antibody, 1:100; Cell
Signaling, Danvers, MA, USA) or phospho-cofilin (ser-3) (rabbit monoclonal
antibody, 1:100; Cell Signaling, Danvers, MA, USA) antibodies and tetramethyl
rhodamine isothiocyanate-phalloidin (1:500; Sigma-Aldrich, St Louis, MO, USA)
as an F-actin marker. The criteria for collapsed growth cones were a total loss of
filopodia and lamellipodia and a strong decrease in F-actin content. Data were
statistically analysed using one-way analysis of variance (ANOVA) followed by a
Dunnett’s post-test (GraphPad Prism software 4.0; GraphPad Software Inc., San
Diego, CA, USA). P-values o0.05 were considered significant (**Po0.01).
Tissue processing and immunostainings. Embryo heads and postnatal cochleae
were fixed for 2–24 h (time according to the sample size) in 4% paraformaldehyde
and, if needed, decalcified for at least three days (0.1 M EDTA in PBS). Whole-
mount cochleae, sections or explants were incubated overnight at 4 C with pri-
mary antibodies directed against ephrin-A5 (goat IgG, 1:100; Santa Cruz Bio-
technology, Santa Cruz, CA, USA), green fluorescent protein (rat monoclonal
IgG2a, 1:250; Gentaur, London, UK), peripherin (mouse monoclonal IgG1, 1:250;
Acris Antibodies GmbH, Herford, Germany), bIII-tubulin (Tuj1 antibody, mouse
monoclonal IgG2a, 1:2000; Covance Reaserch Products, Princeton, NJ, USA),
myosin-VII (rabbit IgG, 1:250; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and parvalbumin (goat IgG, 1:5000; Swant, Marly, Switzerland), both specific
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markers for HCs52,53, neurofilament H (rat IgG, clone TA51, 1:500; Millipore,
Billerica, MA, USA) and CtBP2/RIBEYE (purified mouse IgG1, 1:250; BD
Transduction Laboratories, Mississauga, ON, Canada). Tissues were then
incubated for 1 h with either Rhodamine Red X-, fluorescein isothiocyanate- or
Cy5-conjugated goat anti-mouse, anti-rabbit or anti-rat IgGs secondary antibodies
(Jackson Immunoresearch Laboratories, Suffolk, UK).
For glutamate receptor subunit 2/3 (rabbit IgG, 1:200; Chemicon, Temecula, CA,
USA)/CtBP2 double immunolabeling, freshly dissected apical cochlear turns were
fixed with 99.9% ethanol (Merck, Darmstadt, Germany) for 20 min at  20 C.
Confocal microscopy, image analysis and quantifications. Fluorescence pictures
were acquired using the Olympus Fluoview FV1000 confocal system equipped with
the Olympus IX81 inverted microscope (Olympus Europa GmbH, Germany) or the
Leica SP2 confocal microscope (Leica, Wetzlar, Germany). Unless otherwise
mentioned, fields were acquired using Z-scan, with a step of 1 mm between
each confocal plane. For comparison between genotypes and culture conditions, all
preparations were analysed at the same time, using the same acquisition parameters.
On whole-mount P2, 3-month and P14 cochleae, we considered, respectively, the
proportion of NF-Hþ fibres beneath and beyond the row of IHCs and the number
NF-Hþ /peripherin– fibres between IHC and OHC layers. Each explant was cut into
three fragments consisting of apical, middle and basal turns of cochleae from WT,
ephrin-A5 / and EphA4EGFP/EGFP mice, and one corresponding region (as shown,
for the apical turn, in Fig. 2a,b (magnifications)) measuring roughly 200mm was
considered for quantification. To avoid multiplication of graphs and statistics, in
each case, data from individual turns were collapsed to give a single cochlea figure. At
P2 and at 3 months, values were expressed as a percentage of fibres targeting the
OHC layer. At P14, values were expressed as a mean axon number per 100mm of
cochlear length for each animal. Data were statistically analysed using a Student’s t-
test. P-values o0.05 were considered significant (**Po0.01; ***Po0.001). On
whole-mount P14 cochleae, type II fibres were classified in two groups of length
o200 or 4200mm after entering the OC. Measures were done using ImageJ soft-
ware (NIH). Data were statistically analysed using Student’s t-test. P-values o0.05
were considered significant (*Po0.05; **Po0.01).
For each organotypic culture condition, we compared the number of bIII-
tubulinþ fibres beneath and beyond the row of IHCs, and values were expressed as a
percentage of fibres targeting the OHC layer. Depending on the number of condi-
tions to be compared, data were statistically analysed using a Student’s t-test or a
one-way ANOVA test followed by a Dunnett’s post-test. P-values o0.05 were
considered significant (**Po0.01; ***Po0.001).
CtBP2þ synaptic ribbons were quantified in about 12–15 IHCs and corre-
sponding tangential OHCs in similar regions from apical, middle and basal turns of
P14 cochleae from WT and ephrin-A5 / or EphA4EGFP/EGFP mice. The number of
ribbons was divided by the total number of IHC nuclei to obtain the number of
synaptic ribbons/IHC or/row of OHCs (classically corresponding to three OHCs). In
a subset of cochleae in which co-labelling for ribbons and postsynaptic AMPA
receptors was performed, juxtaposed spots of ribbon and AMPA receptor immu-
nofluorescence were counted and expressed as the number of synapses per IHC.
Data were statistically analysed using a Student’s t-test. P-values o0.05 were con-
sidered significant (*Po0.05; **Po0.01; ***Po0.001).
Total SGNs and type II SGNs from WT, ephrin-A5 / or EphA4EGFP/EGFP P2
mice were quantified using a stereological reconstruction method54. Data were
statistically analysed using a Student’s t-test. In organotypic cultures, SGN
population was quantified by considering three fields of SG per condition. Values
were expressed as a mean number of SGNs per 10000mm2. Depending on the
number of conditions to be compared, data were statistically analysed using a
Student’s t-test or a one-way ANOVA test. Ephrin-A5þ and EphA4þ SGNs were
quantified at apical, middle and basal turns of E18—P6 cochleae after in situ
hybridization (ISH) and bIII-tubulin immunolabeling. Roughly 500 SGNs were
quantified for each animal and for each probe. Data were expressed as a percentage
of SGNs expressing ephrin-A5 or EphA4.
RNA ISH. ISH was performed using digoxigenin-labelled ephrin-A5 (ref. 55) and
EphA4 (ref. 56) riboprobes as previously described57. If needed, slides were
classically immunolabeled with peripherin or bIII-tubulin antibodies.
In vitro stripe assay. Stripe assay using recombinant control IgG-Fc or pre-
clustered ephrin-A5-Fc was performed as previously described58. Ephrin-A5 stripes
were labelled using anti-human IgG (Fc-specific)-Cy3-conjugated antibodies
(1:100; Sigma-Aldrich, St. Louis, MO, USA). SGs from newborn mice were
dissected and plated on stripes for 24–48 h. Neurons were then labelled using
Calcein AM (1:1000; Invitrogen Molecular Probes, Eugene, OR, USA) for 1 h at
37 C, and pictures were acquired using the Olympus Fluoview FV1000 confocal
system. Data were analysed by comparing the percentage of growth cones present
in control IgG-Fc or ephrin-A5-Fc stripes using a Student’s t-test. P-value o0.05
was considered significant (**Po0.01).
ABR recording. Three-month-old mice were recorded as previously described59.
ABR threshold was determined by detection of any wave in the complex. Data were
statistically analysed using a Student’s t-test. P-values o0.05 were considered
significant (*Po0.05; **Po0.01).
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